Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

1.5K
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
1.5K
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

712
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
712
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

359
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
359
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

333
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
333
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

426
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
426
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

357
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
357

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ebnm: An R Package for Solving the Empirical Bayes Normal Means Problem Using a Variety of Prior Families.

Journal of statistical software·2026
Same author

Empirical Bayes Covariance Decomposition, and a Solution to the Multiple Tuning Problem in Sparse PCA.

Journal of computational and graphical statistics : a joint publication of American Statistical Association, Institute of Mathematical Statistics, Interface Foundation of North America·2026
Same author

Non-negative matrix factorization algorithms generally improve topic model fits.

Statistics and computing·2026
Same author

Semi-parametric empirical bayes method for multiplet detection in snATAC-seq with probabilistic multi-omic integration.

PLoS computational biology·2026
Same author

Diagnosing scientific replicability through probabilistic distinguishability.

Bioinformatics (Oxford, England)·2026
Same author

Plasma metabolite association profiles for type 2 diabetes genetic clusters in Finnish men.

Diabetologia·2026
Same journal

Genetic survey of biomarkers at early and mid-pregnancy identifies pregnancy-specialized immune regulation.

PLoS genetics·2026
Same journal

Argonaute proteins orchestrate Meiotic Sex Chromosome Inactivation and timing of the spermatogenic transcriptional program.

PLoS genetics·2026
Same journal

Genome wide association study meta-analysis of neuropathologic lesions of Alzheimer's disease and related dementias in a multi-site autopsy cohort.

PLoS genetics·2026
Same journal

Microtubule stiffening by the doublecortin-domain protein ZYG-8 contributes to mitotic spindle orientation during zygote division in Caenorhabditis elegans.

PLoS genetics·2026
Same journal

Multiple instance fine-mapping: Predicting causal regulatory variants with a deep sequence model.

PLoS genetics·2026
Same journal

Nuclear ubiquitin-conjugating enzyme TrUbc4 and F-box protein TrFwd1-mediated modification of Cre1 in Trichoderma reesei establishes a regulatory mechanism for carbon catabolite repression.

PLoS genetics·2026
See all related articles

Related Experiment Video

Updated: May 1, 2026

2D and 3D Echocardiography in the Axolotl Ambystoma Mexicanum
09:53

2D and 3D Echocardiography in the Axolotl Ambystoma Mexicanum

Published on: November 29, 2018

14.7K

A statistical framework for joint eQTL analysis in multiple tissues.

Timothée Flutre1, Xiaoquan Wen, Jonathan Pritchard

  • 1Department of Human Genetics, University of Chicago, Chicago, Illinois, United States of America.

Plos Genetics
|May 15, 2013
PubMed
Summary
This summary is machine-generated.

This study introduces a new statistical framework for identifying expression Quantitative Trait Loci (eQTLs) across multiple tissues. The method enhances the detection of shared regulatory variants, improving our understanding of gene regulation in complex organisms.

More Related Videos

Robust Comparison of Protein Levels Across Tissues and Throughout Development Using Standardized Quantitative Western Blotting
08:13

Robust Comparison of Protein Levels Across Tissues and Throughout Development Using Standardized Quantitative Western Blotting

Published on: April 9, 2019

13.6K
A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions
09:00

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

Published on: April 18, 2025

1.4K

Related Experiment Videos

Last Updated: May 1, 2026

2D and 3D Echocardiography in the Axolotl Ambystoma Mexicanum
09:53

2D and 3D Echocardiography in the Axolotl Ambystoma Mexicanum

Published on: November 29, 2018

14.7K
Robust Comparison of Protein Levels Across Tissues and Throughout Development Using Standardized Quantitative Western Blotting
08:13

Robust Comparison of Protein Levels Across Tissues and Throughout Development Using Standardized Quantitative Western Blotting

Published on: April 9, 2019

13.6K
A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions
09:00

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

Published on: April 18, 2025

1.4K

Area of Science:

  • Genetics
  • Systems Biology
  • Bioinformatics

Background:

  • Expression Quantitative Trait Loci (eQTLs) studies link genetic variants to gene expression.
  • Current eQTL analyses are often limited to single tissues or cell types.
  • Understanding organismal phenotypes requires analyzing gene regulation across multiple tissues.

Purpose of the Study:

  • To develop a statistical framework for detecting eQTLs in multiple tissues simultaneously.
  • To model the tissue-specific activity and sharing patterns of eQTLs.
  • To increase statistical power for identifying eQTLs compared to tissue-by-tissue analyses.

Main Methods:

  • Developed a novel statistical framework to model eQTL activity across multiple tissues.
  • Explicitly modeled the sharing and inactivity of eQTLs across different subgroups.
  • Applied the framework to re-analyze existing eQTL data from B cells, T cells, and fibroblasts.

Main Results:

  • The new framework significantly increased the power to detect eQTLs compared to traditional methods.
  • Identified 63% more genes with eQTLs at a False Discovery Rate (FDR) of 0.05.
  • Results suggest a majority of detectable eQTLs are shared across the three analyzed tissue types.

Conclusions:

  • The proposed statistical framework offers a more powerful approach for multi-tissue eQTL analysis.
  • This method improves the estimation of shared eQTLs and addresses limitations of previous analyses.
  • Findings indicate widespread sharing of eQTLs across different cell types, providing insights into conserved regulatory mechanisms.